Lantern Raises $30 Million to Scale Specialty Care Platform and Accelerate Employer Growth

New updates have been reported about Lantern.

Lantern has secured a $30 million growth investment led by Morgan Health, a JPMorgan Chase business focused on employer-sponsored healthcare, and Echo Health Ventures, giving the specialty care platform additional capital to expand its reach among public and private employers and health plans across the U.S. The company, which now serves 12 million members, positions the funding as fuel to further scale its model of lowering specialty care costs while improving outcomes in surgery, cancer, and infusion services.

Lantern’s core “Network of Excellence” strategy departs from traditional centers-of-excellence by contracting directly with high-performing local providers, achieving negotiated rates for surgery and related services up to 55% below average commercial reimbursement and generating about 4% savings on total healthcare costs for customers, equating to more than $1 billion in cumulative employer savings. Its clinically vetted network, built on more than 300 appropriateness and outcome measures, has been associated with fewer complications, strong functional recovery, high surgical avoidance where appropriate, and downstream cost reductions, while its concierge support model posts an 85 NPS and is designed to improve member navigation.

The new capital follows a year of rapid expansion in which Lantern added over 100 clients, including the North Carolina State Health Plan, which tapped Lantern to manage surgical care for more than 500,000 covered lives as it confronts a projected $1.4 billion deficit. Lantern has also brought on national employers such as Thermo Fisher Scientific, Amtrak, Hillsborough County Schools, and the Cleveland Bakers and Teamsters Health & Welfare Fund, underscoring demand among large plan sponsors for specialty cost containment solutions.

Strategically, Lantern has broadened both scale and capabilities through the addition of Specialist Management Solutions in January, which contributed roughly 4 million members and an AI-native outreach platform aimed at identifying and engaging patients earlier in their care journey. The company has also expanded cancer navigation via a partnership with AccessHope, enabling community-based members to receive expert review from National Cancer Institute-designated comprehensive cancer centers, and launched a strategic relationship with Quantum Health to embed outcomes-based specialty care into employer offerings nationwide.

Lantern’s leadership frames these moves as a bid to “restore basic market dynamics” in specialty care, using cost analytics, detailed clinical data, and value-based contracting to steer members to high-value care close to home while easing pressure on employer healthcare budgets. Backers Morgan Health and Echo Health Ventures view Lantern’s model as differentiated in a high-cost segment where employers are facing double-digit price escalation and rising employee expectations for navigation support, suggesting further growth opportunities as health plans deepen partnerships and more large sponsors seek measurable savings without sacrificing quality or access.